These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Effects of patent ductus arteriosus on left ventricular output and organ blood flows in preterm infants with respiratory distress syndrome treated with surfactant. Shimada S; Kasai T; Konishi M; Fujiwara T J Pediatr; 1994 Aug; 125(2):270-7. PubMed ID: 8040777 [TBL] [Abstract][Full Text] [Related]
10. Long-term pulmonary consequences of respiratory distress syndrome in preterm infants treated with exogenous surfactant. Abbasi S; Bhutani VK; Gerdes JS J Pediatr; 1993 Mar; 122(3):446-52. PubMed ID: 8441104 [TBL] [Abstract][Full Text] [Related]
11. Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome. Soll R; Ozek E Cochrane Database Syst Rev; 2009 Jan; (1):CD000141. PubMed ID: 19160177 [TBL] [Abstract][Full Text] [Related]
12. Hemodynamic prediction of complications in neonatal respiratory distress syndrome. Seppänen MP; Kääpä PO; Kero PO J Pediatr; 1995 Nov; 127(5):780-5. PubMed ID: 7472836 [TBL] [Abstract][Full Text] [Related]
13. Changes in hemodynamics after rescue surfactant administration. Katheria AC; Leone TA J Perinatol; 2013 Jul; 33(7):525-8. PubMed ID: 23328925 [TBL] [Abstract][Full Text] [Related]
14. Surfactant replacement therapy for preterm and term neonates with respiratory distress. Polin RA; Carlo WA; ; Pediatrics; 2014 Jan; 133(1):156-63. PubMed ID: 24379227 [TBL] [Abstract][Full Text] [Related]
15. [Intracardiac hemodynamic changes in the newborns with respiratory distress syndrome]. Perepelitsa SA; Korotkaia MV; Pavlenko OV; Golubev AM Anesteziol Reanimatol; 2009; (1):37-40. PubMed ID: 19348326 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the effect of three doses of a synthetic surfactant on the alveolar-arterial oxygen gradient in infants weighing > or = 1250 grams with respiratory distress syndrome. American Exosurf Neonatal Study Group II. Berry DD; Pramanik AK; Philips JB; Buchter DS; Kanarek KS; Easa D; Kopelman AE; Edwards K; Long W J Pediatr; 1994 Feb; 124(2):294-301. PubMed ID: 8301442 [TBL] [Abstract][Full Text] [Related]
17. Pulmonary mechanics and energetics in preterm infants who had respiratory distress syndrome treated with synthetic surfactant. Bhutani VK; Abbasi S; Long WA; Gerdes JS J Pediatr; 1992 Feb; 120(2 Pt 2):S18-24. PubMed ID: 1735846 [TBL] [Abstract][Full Text] [Related]
18. Changes in pulmonary artery pressure in infants with respiratory distress syndrome following treatment with Exosurf. Hamdan AH; Shaw NJ Arch Dis Child Fetal Neonatal Ed; 1995 May; 72(3):F176-9. PubMed ID: 7796233 [TBL] [Abstract][Full Text] [Related]
19. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Stevens TP; Blennow M; Soll RF Cochrane Database Syst Rev; 2004; (3):CD003063. PubMed ID: 15266470 [TBL] [Abstract][Full Text] [Related]
20. Changes in pulmonary mechanics after the administration of surfactant to infants with respiratory distress syndrome. Davis JM; Veness-Meehan K; Notter RH; Bhutani VK; Kendig JW; Shapiro DL N Engl J Med; 1988 Aug; 319(8):476-9. PubMed ID: 3405254 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]